Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study

Summary

The primary objective of this study is to evaluate the efficacy of MHB018A injection compared with placebo in participants with active moderate-to-severe TED.

Timeline

Start

2026-12

Primary completion

2028-07

Completion

2029-07

Drugs

Indications